9,10-dimethyl-1,2-benzanthracene has been researched along with atenolol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andresen, BT; Chang, A; Huang, KM; Huang, Y; Jackson, EK; Kanassatega, RS; Liu, MM; Orlando, R; Parsa, C; Thakkar, A; Yeung, S | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and atenolol
Article | Year |
---|---|
Prevention of skin carcinogenesis by the β-blocker carvedilol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenergic beta-Antagonists; Animals; Anticarcinogenic Agents; Atenolol; Carbazoles; Carvedilol; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Isoproterenol; Mice; Mutation; Neoplasm Transplantation; Propanolamines; Skin Neoplasms; Transcription Factor AP-1 | 2015 |